FUSHILAI released its performance for the first three quarters, with a net profit attributable to the parent company of 73.3966 million yuan, an increase of 430.16%

FUSHILAI released its third-quarter report for 2025, with operating revenue of 323 million yuan in the first three quarters, a year-on-year increase of 3.23%. The net profit attributable to the parent company was 73.3966 million yuan, a year-on-year increase of 430.16%. The net profit after deducting non-recurring gains and losses was 2.5119 million yuan, a year-on-year increase of 119.80%. The basic earnings per share were 0.8099 yuan

FUSHILAI: Cumulatively repurchased 950,000 shares

FUSHILAI announced that as of August 15, 2025, the company has cumulatively repurchased 950,000 shares through a dedicated securities account for stock repurchase via centralized bidding, accounting for 1.0363% of the company's current total share capital, with a highest transaction price of 38.56 yuan/share and a lowest transaction price of 33.04 yuan/share, totaling a fund amount of 33.9052 million yuan. The company's repurchase complies with relevant laws and regulations and the established share repurchase plan

FUSHILAI: The total number of shares repurchased by the company is 400,000 shares

FUSHILAI announced that as of July 31, 2025, the company has repurchased a total of 400,000 shares through a dedicated securities account for stock repurchase via centralized bidding, accounting for 0.4363% of the company's current total share capital, with a highest transaction price of 35.72 yuan/share, a lowest transaction price of 33.04 yuan/share, and a total amount of funds used of 13.8157 million yuan. The company's repurchase complies with relevant laws and regulations and the established share repurchase plan

Pharmaceutical stocks continue to be strong, FUSHILAI hits the 20% limit up, Tuoxin Pharmaceutical and Cosunter rise over 10%, Xizang Weixinkang Pharmaceutical, MEDISAN and several other stocks hit the limit up

FUSHILAI plans to spend between 20 million and 40 million yuan to implement a buyback

According to the Zhitong Finance APP, FUSHILAI announced that the company plans to use its own funds to repurchase company shares for the implementation of an equity incentive plan or employee stock ownership plan. The total amount of funds for the share repurchase will not be less than 20 million yuan (inclusive) and not exceed 40 million yuan (inclusive), with the repurchase price not exceeding 40 yuan per share (inclusive). The implementation period for the share repurchase will be within 12 months from the date the company's board of directors approves this repurchase plan